Page last updated: 2024-08-17

dimethyl sulfone and tamoxifen

dimethyl sulfone has been researched along with tamoxifen in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, SH; Cho, BW; Darvin, P; Hwang, TS; Joung, YH; Kang, DY; Kim, DN; Kim, HS; Kim, SY; Kim, WS; Lee, HK; Park, JH; Park, KD; S P, N; Yang, YM; Yoo, YB	1

Other Studies

1 other study(ies) available for dimethyl sulfone and tamoxifen

Article	Year
The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts. BMC cancer, 2015, Jun-19, Volume: 15 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Estrogen Receptor alpha; Female; Humans; Janus Kinase 2; Neoplasm Metastasis; Receptors, Somatomedin; Signal Transduction; STAT5 Transcription Factor; Sulfones; Tamoxifen; Xenograft Model Antitumor Assays	2015

Article

Year

The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts.

BMC cancer, 2015, Jun-19, Volume: 15

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Estrogen Receptor alpha; Female; Humans; Janus Kinase 2; Neoplasm Metastasis; Receptors, Somatomedin; Signal Transduction; STAT5 Transcription Factor; Sulfones; Tamoxifen; Xenograft Model Antitumor Assays

2015